736 related articles for article (PubMed ID: 12437574)
21. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
22. Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.
Zhang F; Ström AL; Fukada K; Lee S; Hayward LJ; Zhu H
J Biol Chem; 2007 Jun; 282(22):16691-9. PubMed ID: 17403682
[TBL] [Abstract][Full Text] [Related]
23. SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron.
Mitsui S; Otomo A; Sato K; Ishiyama M; Shimakura K; Okada-Yamaguchi C; Warabi E; Yanagawa T; Aoki M; Shang HF; Hadano S
Neurochem Int; 2022 Sep; 158():105364. PubMed ID: 35640762
[TBL] [Abstract][Full Text] [Related]
24. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
25. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
[TBL] [Abstract][Full Text] [Related]
26. Bee venom effects on ubiquitin proteasome system in hSOD1(G85R)-expressing NSC34 motor neuron cells.
Kim SH; Jung SY; Lee KW; Lee SH; Cai M; Choi SM; Yang EJ
BMC Complement Altern Med; 2013 Jul; 13():179. PubMed ID: 23866691
[TBL] [Abstract][Full Text] [Related]
27. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70.
Koyama S; Arawaka S; Chang-Hong R; Wada M; Kawanami T; Kurita K; Kato M; Nagai M; Aoki M; Itoyama Y; Sobue G; Chan PH; Kato T
Biochem Biophys Res Commun; 2006 May; 343(3):719-30. PubMed ID: 16563356
[TBL] [Abstract][Full Text] [Related]
28. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
[TBL] [Abstract][Full Text] [Related]
29. Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Hong Y; Taylor DM; Minotti S; Figlewicz DA; Durham HD
J Neurochem; 2008 Jun; 105(6):2353-66. PubMed ID: 18315558
[TBL] [Abstract][Full Text] [Related]
30. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Shibata N
Neuropathology; 2001 Mar; 21(1):82-92. PubMed ID: 11304046
[TBL] [Abstract][Full Text] [Related]
31. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase.
Higashi S; Tsuchiya Y; Araki T; Wada K; Kabuta T
Neurochem Int; 2010 Dec; 57(8):906-13. PubMed ID: 20933032
[TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis.
Hoffman EK; Wilcox HM; Scott RW; Siman R
J Neurol Sci; 1996 Jul; 139(1):15-20. PubMed ID: 8836967
[TBL] [Abstract][Full Text] [Related]
33. Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients.
Keskin I; Forsgren E; Lange DJ; Weber M; Birve A; Synofzik M; Gilthorpe JD; Andersen PM; Marklund SL
PLoS One; 2016; 11(2):e0150133. PubMed ID: 26919046
[TBL] [Abstract][Full Text] [Related]
34. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
35. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
[TBL] [Abstract][Full Text] [Related]
36. Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1.
Oono M; Okado-Matsumoto A; Shodai A; Ido A; Ohta Y; Abe K; Ayaki T; Ito H; Takahashi R; Taniguchi N; Urushitani M
J Neurochem; 2014 Feb; 128(3):403-18. PubMed ID: 24032595
[TBL] [Abstract][Full Text] [Related]
37. Assessing the role of immuno-proteasomes in a mouse model of familial ALS.
Puttaparthi K; Van Kaer L; Elliott JL
Exp Neurol; 2007 Jul; 206(1):53-8. PubMed ID: 17482163
[TBL] [Abstract][Full Text] [Related]
38. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.
Bruijn LI; Houseweart MK; Kato S; Anderson KL; Anderson SD; Ohama E; Reaume AG; Scott RW; Cleveland DW
Science; 1998 Sep; 281(5384):1851-4. PubMed ID: 9743498
[TBL] [Abstract][Full Text] [Related]
39. Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation.
Wang J; Xu G; Li H; Gonzales V; Fromholt D; Karch C; Copeland NG; Jenkins NA; Borchelt DR
Hum Mol Genet; 2005 Aug; 14(16):2335-47. PubMed ID: 16000321
[TBL] [Abstract][Full Text] [Related]
40. DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity.
Yamashita S; Mori A; Kimura E; Mita S; Maeda Y; Hirano T; Uchino M
J Neurochem; 2010 May; 113(4):860-70. PubMed ID: 20202083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
